ATRICURE INC's ticker is ATRC and the CUSIP is 04963C209. A total of 103 filers reported holding ATRICURE INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,124 | +117.4% | 48,500 | +144.9% | 0.01% | +125.0% |
Q2 2023 | $977 | -61.6% | 19,800 | -67.8% | 0.00% | 0.0% |
Q1 2023 | $2,547 | +180.2% | 61,500 | +200.0% | 0.00% | 0.0% |
Q4 2022 | $909 | -99.9% | 20,500 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $801,000 | -4.3% | 20,500 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $837,000 | -33.9% | 20,500 | +6.2% | 0.00% | -20.0% |
Q1 2022 | $1,267,000 | -5.5% | 19,300 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $1,341,000 | -0.1% | 19,300 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $1,342,000 | -13.6% | 19,300 | -1.5% | 0.01% | -16.7% |
Q2 2021 | $1,554,000 | +94.0% | 19,600 | -2.5% | 0.01% | +100.0% |
Q3 2020 | $801,000 | -11.3% | 20,100 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $903,000 | +17.0% | 20,100 | -12.6% | 0.00% | 0.0% |
Q1 2020 | $772,000 | – | 23,000 | – | 0.00% | – |
Q1 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2015 | $354,000 | +50.6% | 15,800 | +46.9% | 0.00% | +100.0% |
Q3 2015 | $235,000 | – | 10,759 | – | 0.00% | – |
Q3 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q2 2014 | $531,000 | +431.0% | 28,900 | +445.0% | 0.00% | – |
Q1 2014 | $100,000 | – | 5,303 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 350,000 | $13,965,000 | 4.30% |
SECTORAL ASSET MANAGEMENT INC | 708,717 | $28,278,000 | 2.43% |
First Light Asset Management, LLC | 561,018 | $22,385,000 | 2.29% |
DAFNA Capital Management LLC | 133,229 | $5,316,000 | 1.73% |
PERKINS CAPITAL MANAGEMENT INC | 44,350 | $1,770,000 | 1.63% |
PURA VIDA INVESTMENTS, LLC | 645,003 | $25,736,000 | 1.33% |
Acuitas Investments, LLC | 46,353 | $1,849,000 | 1.30% |
EMERALD MUTUAL FUND ADVISERS TRUST | 477,064 | $19,035,000 | 0.84% |
EMERALD ADVISERS, LLC | 500,848 | $19,984,000 | 0.82% |
Orbimed Advisors | 1,228,189 | $49,005,000 | 0.62% |